This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Debiopharm Research & Manufacturing Sa. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Marie-Anne Bardet: Innovator in Pharmaceutical Composition
Introduction
Marie-Anne Bardet is a notable inventor based in Maracon, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of slow-release compositions. Her innovative work has led to the creation of a patented pharmaceutical composition that enhances the delivery of active substances.
Latest Patents
Marie-Anne Bardet holds a patent for a slow-release pharmaceutical composition made of microgranules. This composition is designed for the slow release of an active substance over a period covering at least six months after injection. The formulation includes microparticles made of a copolymer of the PLGA type, which incorporates a water-insoluble peptide salt. The copolymer consists of at least 75% lactic acid and has an inherent viscosity between 0.1 and 0.9 dl/g. The microparticles have a specific size distribution, ensuring effective delivery of the active substance.
Career Highlights
Throughout her career, Marie-Anne has worked with prominent companies in the pharmaceutical industry. She has been associated with Debiopharm Research & Manufacturing SA and Debiopharm International SA. Her work in these organizations has allowed her to contribute to the advancement of pharmaceutical technologies.
Collaborations
Marie-Anne Bardet has collaborated with esteemed professionals in her field, including Bertrand Ducrey and Patrick Garrouste. These collaborations have further enriched her research and development efforts.
Conclusion
Marie-Anne Bardet is a pioneering inventor whose work in pharmaceutical compositions has made a significant impact on drug delivery systems. Her innovative approach continues to influence the field, showcasing the importance of research and development in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile